Health Technology Assessment Goes Online

LONDON, June 15, 2011 -

Pharma IQ is pioneering new HTA discussion platform with launch
of the first ever HTA Online event - href="https://www.htaforumonline.com/?utm_campaign=Press%20Releases%20brochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001%20PR2">
Global HTA and CER Forum, which will take an innovative form of
12 online session over the course of August.

Health Technology Assessment has recently observed an
unprecedented global  expansion. Clinical and cost
effectiveness are assessed for pharmaceuticals in Australia, Canada
and the UK, while clinical benefit is the main focus in France and
Germany for new drugs. CER is rapidly gaining momentum in the US to
inform federal funding decisions, while commercial US payers use
clinical and economic evidence in formulary listings.

Over 12 speakers from 10 countries, including 5 HTA agencies,
will deliver 13 presentations:

• National Institute for Health and Clinical Excellence
 (NICE)

• Patented Medicine Prices Review Board (PMPRB)

• Spanish Agency for Health Technology  Assessment
(AETS)

• Roche Products

• GlaxoSmithKline

• HIQA

• Office of Health Economics

• F. Hoffmann-La Roche

• Amgen

Key topics to discussed by expert panel include:

• Speeding the reimbursement processes with first-hand input from
  prominent HTA bodies: NICE, OHE and HIQA
• Exploring the efforts of standardisation of HTA in Europe

• Implementing a best practice approach to value-based
  pricing

• Analysing the finer points of performance-based reimbursement
  and its impact

• Aligning HTA strategies with insight from leading pharma and
  biotech companies:  GSK, Roche and Amgen

• Designing product development programmes to maximise
  reimbursement success

The online form of the event is meant to help to reach the
global audience and enable experts from Europe to have a live
discussion with their colleagues in US, Canada and Australia
without the need to leave their desk.

‘ In response to the fact that we operate in a time of
reduced budgets and time, this conference takes place 100%
online, therefore no travelling expenses or timing
conflicts would occur’ says Andrea Charles, Global HTA and CER
Forum Director. ‘What’s more, if someone
misses a session, it can always be
accesses online as a recorded version of live
session. It also means thatnow we can easily access global
audience and industry experts from United States will be able to
network easily with their colleagues from Europe without the need
of leaving their desk or home’.

To find out more about how href="https://www.htaforumonline.com/?utm_campaign=Press%20Releases%20brochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001%20PR2">
Global HTA and CER Forum plans to bring together word-wide
renowned experts in the field, or to join the online discussion,
visit the event website: href="www.htaforumonline.com">www.htaforumonline.com

href="https://www.htaforumonline.com/?utm_campaign=PressReleasesbrochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001PR2">
https://www.htaforumonline.com/?utm_campaign=PressReleasesbrochure&utm_medium=online&utm_source=Press_ReleasesBR&MAC=20511.001PR2

For more information, images or press passes,
contact:

PHARMA IQ
Joanna Checinska, Marketing Manager
Email: joanna.checinska@iqpc.co.uk
Phone: +44(0)2073689300

.